Manganese-metalloporphyrin (ATN-10) as a tumor-localizing agent: Magnetic resonance imaging and inductively coupled plasma atomic emission spectroscopy study with experimental brain tumors

Neurosurgery

Volumn 42, Issue 6, 1998, Pages 1332-1338

  Yamamoto, Tetsuya ^a   Matsumura, Akira ^a   Shibata, Yasushi ^a   Fujimori, Hiroyuki ^a   Nakai, Kei ^a   Yoshida, Fumiyo ^b   Nose, Tadao ^a   Sakata, Isao ^c   Nakajima, Susumu ^d   Miwa, Naoto ^e  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b TSUKUBA UNIVERSITY OF TECHNOLOGY   (Japan)

^c Toyo Hakka Co Ltd   (Japan)

^d ASAHIKAWA MEDICAL COLLEGE   (Japan)

^e Nihon Schering   (Japan)

Author keywords

Brain neoplasms; Contrast enhancement; Magnetic resonance imaging; Manganese; Metalloporphyrin

Indexed keywords

MANGANESE DERIVATIVE; MANGANESE METALLOPORPHYRIN; METALLOPORPHYRIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC EMISSION SPECTROMETRY; BRAIN EDEMA; BRAIN NECROSIS; CONTROLLED STUDY; GLIOMA; HISTOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN EDEMA; BRAIN NEOPLASMS; CEREBROVASCULAR DISORDERS; DEUTEROPORPHYRINS; GLIOMA; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MALE; METHODS; NEOPLASMS, EXPERIMENTAL; RATS; RATS, INBRED F344;

EID: 20244368932     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199806000-00083     Document Type: Article

References (21)

1. Houkin K, Abe H, Hashiguchi Y, Seri S: Magnetic resonance imaging of cold injury-induced brain edema in rats. Neurol Med Chir (Tokyo) 36:72-77, 1996.
2. Huang LR, Straubinger RM, Kahl SB, Koo MS, Alletto JJ, Mazurchuk R, Chau RI, Thamer SL, Fiel RJ: Boronated metalloporphyrins: A novel approach to the diagnosis and treatment of cancer using contrast-enhanced MR imaging and neutron capture therapy. J Magn Reson Imaging 3:351-356, 1993.
3. Ikezaki K, Nomura T, Takahashi M, Fritz-Zieroth B, Inamura T, Fukui M: Selective and prolonged MRI enhancement by Mn-TPPS in an experimental rat brain tumour with peripheral benzodiazepine receptors. Neurol Res 16:393-397, 1994.
4. Kamada K, Houkin K, Hida K, Iwasaki Y, Abe H: Serial changes in metabolism and histology in the cold-injury trauma rat brain model: Proton magnetic resonance imaging and spectroscopy study. Neurol Med Chir (Tokyo) 35:1-7, 1995.
5. Kaye AH: Photoradiation therapy and its potential in the management of neurological rumors. J Neurosurg 69:1-14, 1988.
6. Matsumura A, Shibata Y, Nakagawa K, Yamamoto T, Yoshizawa T, Yoshii Y, Nose T, Sakata I, Nakajima S, Miwa N: Boron-, gadolinium-porphyrin derivatives for neutron capture therapy: MRI and ICP study, in Mishima YM (ed): Cancer Neutron Capture Therapy. New York, Plenum Press, 1996, pp 245-250.
7. Matsumura A, Shibata Y, Yamamoto T, Nakagawa K, Yasuda S, Nakajima S, Sakata I, Yoshizawa Y, Nose T: Mn-metalloporphyrin conjugated with Gd-DTPA (Gd-ATN 10): Tumor enhancement agent for magnetic resonance imaging. Neurol Med Chir (Tokyo) 37:327-331, 1997.
8. Megnim F, Faustino PJ, Lyon RC, Lelkes PI, Cohen JS: Studies on the mechanism of selective retention of porphyrins and metalloporphyrins by cancer cells. Biochim Biophys Acta 929:173-181, 1987.
9. Nakajima S, Hayashi H, Tanaka K, Miyata T, Sakata I, Takemura T: Tumor-localizing Mn[III] metalloporphyrin for magnetic resonance imaging [in Japanese]. Oncologia 26:242-244, 1993.
10. Nakajima S, Takemura T, Sakata I: Tumor-localizing activity of porphyrin and its affinity to LDL, transferrin. Cancer Lett 92:113-118, 1995.
11. 111In-labeled Mn-metalloporphyrin for tumor imaging. Nucl Med Biol 20:231-237, 1993.
12. Naruse S, Horikawa Y, Tanaka C, Hirakawa K, Nishikawa H, Yoshizaki K: Proton nuclear magnetic resonance studies on brain edema. J Neurosurg 56:747-752, 1982.
13. Patronas NJ, Cohen JS, Knop RH, Dwyer AJ, Colcher D, Lundy J, Mornex F, Hambright P, Sohn M, Myers CE: Metalloporphyrin contrast agents for magnetic resonance imaging of human tumors in mice. Cancer Treat Rep 70:391-395, 1986.
14. Peterson DL, Sheridan PJ, Brown WE Jr: Animal models for brain tumors: Historical perspectives and future directions. J Neurosurg 80:865-876, 1994.
15. Policard A, Leuller A: Etude sur les aspects offers par des tumeurs expérimetales examinées a la lumièes de wood. Compt Rend Soc Biol (Paris) 91:1423-1424, 1924.
16. Rudling MJ, Angelin B, Paterson CO, Collins VP: Low density lipoprotein receptor activity in human intracranial tumors and its relation to the cholesterol requirement. Cancer Res 50:483-487, 1990.
17. Spizzirri PG, Hill JS, Kahl SB, Ghiggino KP: Photophysics and intracellular distribution of a boronated porphyrin phototherapeutic agent. Photochem Photobiol 64:975-983, 1996.
18. Takemura T, Ohta N, Nakajima S, Sakata I: Critical importance of the triplet lifetime of photosensitizer in photodynamic therapy of tumor. Photochem Photobiol 50:339-344, 1989.
19. Weizsaecker M, Deen DF, Rosenblum ML, Hoshino T, Gutin PH, Barker M: The 9L rat brain tumor: Description and application of an animal model. J Neurol 224:183-192, 1981.
20. Wilmes LJ, Hoehn-Berlage M, Els T, Bockhorst K, Eis M, Bohnnekoh P, Hossmann KA: In vivo relaxometry of three brain rumors in the rat: Effect of Mn-TPPS, a tumor-selective contrast agent. J Magn Reson Imaging 3:5-12, 1993.
21. Yamamoto T, Matsumura A, Shibata Y, Yoshizawa T, Fujimori H, Nakagawa K, Nakai K, Yoshii Y, Nose T, Sakata I, Nakajima S: MR imaging using boronated Mn-metalloporphyrin (STA-BX900) for BNCT, in Larsson B, Crawford J, Weinreich R (eds): Advances in Neutron Capture Therapy. Amsterdam, Elsevier, 1997, vol 2, pp 267-270.